NEKTAR THERAPEUTICS — Director's Dealing 2018

Jan 9, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2018-01-04

Reporting Person: WINGER DENNIS L (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-01-04	Common Stock	M	33750	$11.97	Acquired	77000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-01-04	Stock Option	$11.97	M	22500	Disposed	2018-01-15	Common Stock (22500)	Direct
2018-01-04	Stock Option	$11.97	M	11250	Disposed	2018-01-15	Common Stock (11250)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	5000	Indirect

Footnotes

F1: This transaction was made for stock options scheduled to expire on January 15, 2018.